ICP
GSK icon

Interchange Capital Partners’s GSK GSK Stock Holding History

Interchange Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-470
Closed -$21K – 585
2020
Q4 		$21K Buy
+470
New +$21.6K 0.01% 615

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Interchange Capital Partners's GSK Position: Q1 2021 in Review

Interchange Capital Partners sold out of GSK (GSK) in Q1 2021, closing a stake of 470 shares — an estimated $21K sold.

Interchange Capital Partners first reported a position in GSK in Q4 2020 and held it in 1 quarter. The position peaked at $21K in Q4 2020. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Interchange Capital Partners reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 470 GSK shares in Q1 2021, an estimated $21K.
  • Interchange Capital Partners first reported a position in GSK in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's GSK position peaked at $21K in Q4 2020.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.